Alcon Inc. ALC

Set alert

Price alert · ALC

All alert types
73.63 USD +2.18 +3.05%

At close · Nov 2

73.63 0.00 0.00%

After hours · Nov 2, 4:23 PM ET

Bid
73.59 × 400
Ask
73.68 × 200
72.05 Day range 74.19
61.84 52-week range 87.64
YTD
-6.57%
1 year
-0.35%
Open
72.06
Prev close
71.45
Mkt cap
35.59B
Vol
2.20M
Avg vol
1.68M
EPS
1.32
P/E
55.78
Div yield
0.50%
More statistics
Low
72.05
High
74.19
Forward P/E
18.62
Beta
0.72
Short ratio
10.62
Inst. own
62.51%
Dividend
0.36
Ex-div date
May 5, 2026
Earnings
Nov 10, 2026
50-d avg
67.64
200-d avg
71.95
1y target
81.98

5Y chart

Chart tools
Interval

Events in this range
  • Apr 29, 2022Dividend: 0.13
  • May 3, 2022Dividend: 0.205
  • May 9, 2023Dividend: 0.1365
  • May 10, 2023Dividend: 0.23574
  • May 14, 2024Dividend: 0.2647
  • May 13, 2025Dividend: 0.3334
  • May 14, 2025Dividend: 0.3334
  • Aug 19, 2025Earnings: 0.76; estimate 0.71; surprise 7.04%
  • Nov 11, 2025Earnings: 0.79; estimate 0.77; surprise 2.6%
  • Feb 24, 2026Earnings: 0.78; estimate 0.79; surprise -1.27%
  • May 5, 2026Dividend: 0.23203
  • May 5, 2026Earnings: 0.85; estimate 0.8; surprise 6.25%
  • May 6, 2026Dividend: 0.3593
  • Aug 10, 2026Earnings: 0.84; estimate 0.77; surprise 9.09%
  • Sep 22, 2026Rating: Jefferies · Buy → Buy
  • Oct 7, 2026Rating: Barclays · — → Equal-Weight
  • Oct 12, 2026Rating: BTIG · Buy → Buy
  • Oct 21, 2026Rating: Needham · Buy → Buy
  • Oct 27, 2026Rating: Keybanc · Overweight → Overweight
  • Nov 2, 2026Rating: Needham · Buy → Buy
Signals (98)
NameDateAgo
SMA: BullishOct 19, 20262 weeks ago
SMA: BullishOct 19, 20262 weeks ago
MACD: Buy SignalOct 19, 20262 weeks ago
MACD: Sell SignalSep 21, 20261 month ago
SMA: BearishAug 31, 20262 months ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 10, 20262 months ago
MACD: Buy SignalJul 13, 20263 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BearishApr 20, 20266 months ago
MACD: Sell SignalApr 20, 20266 months ago
SMA: BullishApr 13, 20266 months ago
MACD: Buy SignalApr 13, 20266 months ago
SMA: BullishApr 6, 20267 months ago
MACD: Sell SignalMar 16, 20267 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BullishFeb 16, 20268 months ago
SMA: BullishFeb 16, 20268 months ago
SMA: BearishFeb 2, 20269 months ago
SMA: BearishFeb 2, 20269 months ago
SMA: BullishJan 19, 20269 months ago
SMA: BullishJan 19, 20269 months ago
SMA: BearishJan 12, 20269 months ago
SMA: BullishJan 5, 202610 months ago
SMA: BearishDec 29, 202510 months ago
MACD: Buy SignalNov 17, 202511 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BearishAug 18, 20251 year ago
SMA: BullishAug 11, 20251 year ago
SMA: BearishAug 4, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BullishJul 14, 20251 year ago
SMA: BearishMay 19, 20251 year ago
MACD: Sell SignalMay 19, 20251 year ago
SMA: BearishMay 12, 20251 year ago
SMA: BullishApr 14, 20251 year ago
SMA: BullishApr 14, 20251 year ago
SMA: BearishMar 31, 20251 year ago
SMA: BearishMar 31, 20251 year ago
SMA: BullishMar 24, 20251 year ago
SMA: BullishMar 17, 20251 year ago
SMA: BearishMar 10, 20251 year ago
SMA: BearishMar 10, 20251 year ago
SMA: BullishFeb 24, 20251 year ago
MACD: Buy SignalFeb 3, 20251 year ago
SMA: BullishJan 20, 20251 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BearishOct 14, 20242 years ago
MACD: Sell SignalOct 14, 20242 years ago
RSI: OverboughtAug 26, 20242 years ago
SMA: BullishMay 13, 20242 years ago
MACD: Buy SignalMay 13, 20242 years ago
MACD: Sell SignalApr 22, 20242 years ago
SMA: BearishApr 8, 20242 years ago
SMA: BullishFeb 12, 20242 years ago
SMA: BullishFeb 5, 20242 years ago
SMA: BearishJan 22, 20242 years ago
SMA: BearishJan 15, 20242 years ago
SMA: BullishJan 8, 20242 years ago
MACD: Buy SignalDec 25, 20232 years ago
SMA: BullishDec 11, 20232 years ago
SMA: BearishDec 4, 20232 years ago
SMA: BullishNov 27, 20232 years ago
SMA: BearishSep 25, 20233 years ago
SMA: BearishAug 28, 20233 years ago
SMA: BullishAug 14, 20233 years ago
MACD: Sell SignalAug 14, 20233 years ago
SMA: BearishJul 31, 20233 years ago
MACD: Buy SignalApr 17, 20233 years ago
SMA: BullishApr 3, 20233 years ago
SMA: BullishMar 20, 20233 years ago
SMA: BearishMar 6, 20233 years ago
MACD: Sell SignalMar 6, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BullishDec 19, 20223 years ago
SMA: BearishDec 12, 20223 years ago
SMA: BullishNov 21, 20223 years ago
MACD: Buy SignalNov 14, 20223 years ago
SMA: BullishNov 7, 20223 years ago
MACD: Sell SignalAug 29, 20224 years ago
SMA: BearishAug 8, 20224 years ago
SMA: BearishAug 8, 20224 years ago
SMA: BullishJul 25, 20224 years ago
SMA: BullishJul 18, 20224 years ago
SMA: BearishJul 11, 20224 years ago
MACD: Buy SignalJul 4, 20224 years ago
SMA: BullishJun 27, 20224 years ago
SMA: BearishJun 6, 20224 years ago
SMA: BullishMay 23, 20224 years ago
SMA: BearishApr 25, 20224 years ago
SMA: BullishApr 18, 20224 years ago
SMA: BearishApr 11, 20224 years ago
SMA: BullishMar 28, 20224 years ago
SMA: BearishMar 21, 20224 years ago
SMA: BullishMar 14, 20224 years ago

Key statistics

Market cap
35.59B
Enterprise value
38.38B
Trailing P/E
55.77
Forward P/E
18.62
PEG ratio
1.29
Price / sales
3.28
Price / book
1.65
EPS (TTM)
1.32
Beta
0.72
Dividend yield
0.50%
Payout ratio
26.56%
Profit margin
5.92%
Revenue (TTM)
10.86B
Revenue growth
8.70%
Free cash flow
1.27B
Total cash
1.46B
Total debt
5.30B
Return on equity
2.94%
Shares outstanding
483.40M
Short % of float
0.00%
50-day average
67.64
200-day average
71.95

Analyst view

Consensus: buy

Buy
Price target (mean) 81.98 +11.3% upside
Target (low)
62.00
Target (mean)
81.98
Target (high)
103.00
Ratings (0m) 27 21 buy · 5 hold · 1 sell
  • Strong buy4
  • Buy17
  • Hold5
  • Sell0
  • Strong sell1

Next earnings

Nov 10, 2026

Expected Nov 10, 2026. Consensus EPS estimate 0.89001.

Earnings history

Financials — quick view

All financials
ALC Revenue — quarterly 2.82B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALC Net income — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALC EPS — quarterly 0.00
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ALC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 10, 2026Sep 30, 20260.89———
Aug 10, 2026Jun 30, 20260.770.84+0.07+9.09%
May 5, 2026Mar 31, 20260.800.85+0.05+6.25%
Feb 24, 2026Dec 31, 20250.790.78-0.01-1.27%
Nov 11, 2025Sep 30, 20250.770.79+0.02+2.60%
Aug 19, 2025Jun 30, 20250.710.76+0.05+7.04%

Upgrades / downgrades

ALC analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026NeedhamreitBuyBuy
Oct 27, 2026KeybancmainOverweightOverweight
Oct 21, 2026NeedhamreitBuyBuy
Oct 12, 2026BTIGmainBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 22, 2026JefferiesmainBuyBuy

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
Switzerland
Website
alcon.com

News

Your note

Sign in to keep a note on ALC — it syncs with the Stock Master app.

Institution ownership

ALC institution ownership
Holder% heldSharesValueReported
Vanguard Capital Management LLC2.95%14,749,5821.09BJun 29, 2026
Bank Of New York Mellon Corporation2.61%13,057,962961.33MJun 29, 2026
NORGES BANK2.20%10,976,697808.10MJun 29, 2026
Invesco Ltd.2.08%10,380,332764.20MJun 29, 2026
Aristotle Capital Management, LLC2.00%9,979,069734.66MJun 29, 2026
AKO Capital LLP1.94%9,683,004712.86MJun 29, 2026

Fund ownership

ALC fund ownership
Holder% heldSharesValueReported
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund1.44%7,175,218528.24MJul 30, 2026
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund0.95%4,758,876350.35MJun 29, 2026
iShares Trust-iShares Core MSCI EAFE ETF0.75%3,735,153274.98MSep 29, 2026
ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund0.66%3,283,650241.74MAug 30, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund0.58%2,918,000214.82MJul 30, 2026
MFS SERIES TRUST X-MFS International Intrinsic Equity Fund0.48%2,417,516177.98MAug 30, 2026